• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

    2.305 +0.035 (+1.54%)
    Streaming Delayed Price Updated: 9:57 AM EST, Feb 24, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 160,070
    Open 2.280
    Bid (Size) 2.300 (300)
    Ask (Size) 2.310 (1,300)
    Prev. Close 2.270
    Today's Range 2.270 - 2.330
    52wk Range 2.100 - 5.810
    Shares Outstanding 412,429,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    GoodRx Expands Into Employer Market With Launch of “GoodRx Employer Direct”
    From GoodRx
    Via Business Wire
    News headline image
    GoodRx (GDRX) Reports Earnings Tomorrow: What To Expect
    Healthcare tech company GoodRx (NASDAQ:GDRX) will be announcing earnings results this Wednesday after the bell. Here’s what investors should know. 
    Via StockStory
    Topics Artificial Intelligence World Trade

    Performance

    YTD
    -16.2%
    -16.2%
    1 Month
    -8.5%
    -8.5%
    3 Month
    -16.8%
    -16.8%
    6 Month
    -45.8%
    -45.8%
    1 Year
    -52.4%
    -52.4%

    More News

    Read More
    News headline image
    iRhythm, agilon health, GoodRx, Fortrea, and Myriad Genetics Stocks Trade Down, What You Need To Know
    Via StockStory
    Topics Government World Trade
    News headline image
    GoodRx (GDRX): Buy, Sell, or Hold Post Q3 Earnings?
    Via StockStory
    Topics Supply Chain
    News headline image
    1 Healthcare Stock with Promising Prospects and 2 Facing Challenges
    Via StockStory
    Topics Stocks
    News headline image
    Amazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings. ↗
    Via The Motley Fool
    News headline image
    GoodRx Powers Pricing for Leading Brand Medications on TrumpRx
    From GoodRx
    Via Business Wire
    News headline image
    1 Oversold Stock Set for a Comeback and 2 We Brush Off
    Via StockStory
    News headline image
    GoodRx Earns HITRUST i1 Certification for the Second Consecutive Year, Reinforcing Its Commitment to Protecting Healthcare Data at Scale
    From GoodRx
    Via Business Wire
    News headline image
    1 Stock Under $10 to Target This Week and 2 Facing Headwinds
    Via StockStory
    News headline image
    1 of Wall Street’s Favorite Stock to Target This Week and 2 We Question
    Via StockStory
    News headline image
    GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
    From GoodRx Holdings, Inc.
    Via Business Wire
    News headline image
    Q3 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks
    Via StockStory
    News headline image
    Surescripts and GoodRx Partner to Advance Patient Price Transparency
    From Surescripts
    Via Business Wire
    News headline image
    GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies
    From GoodRx
    Via Business Wire
    News headline image
    Hims & Hers Enters 2026 On Solid Ground — Stock Rises Even After Novo Nordisk Leaves It Off Wegovy Partner List ↗
    Via Stocktwits
    News headline image
    GoodRx Now Offers Novo Nordisk’s Cash Price for the Launch of the Wegovy® Pill
    From GoodRx
    Via Business Wire
    News headline image
    1 Cash-Producing Stock to Keep an Eye On and 2 We Avoid
    Via StockStory
    News headline image
    1 Value Stock to Target This Week and 2 Facing Headwinds
    Via StockStory
    News headline image
    3 Healthcare Stocks We Approach with Caution
    Via StockStory
    Topics Stocks
    News headline image
    GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference
    From GoodRx Holdings, Inc.
    Via Business Wire
    News headline image
    3 Stocks Under $10 That Fall Short
    Via StockStory
    News headline image
    Why GoodRx (GDRX) Stock Is Trading Lower Today
    Via StockStory
    Topics Government
    News headline image
    1 Profitable Stock Worth Your Attention and 2 We Turn Down
    Via StockStory
    News headline image
    Natera, GoodRx, and Bio-Techne Shares Are Soaring, What You Need To Know
    Via StockStory
    Topics Economy Government

    Frequently Asked Questions

    Is GoodRx Holdings, Inc. - Class A Common Stock publicly traded?
    Yes, GoodRx Holdings, Inc. - Class A Common Stock is publicly traded.
    What exchange does GoodRx Holdings, Inc. - Class A Common Stock trade on?
    GoodRx Holdings, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for GoodRx Holdings, Inc. - Class A Common Stock?
    The ticker symbol for GoodRx Holdings, Inc. - Class A Common Stock is GDRX on the Nasdaq Stock Market
    What is the current price of GoodRx Holdings, Inc. - Class A Common Stock?
    The current price of GoodRx Holdings, Inc. - Class A Common Stock is 2.305
    When was GoodRx Holdings, Inc. - Class A Common Stock last traded?
    The last trade of GoodRx Holdings, Inc. - Class A Common Stock was at 02/24/26 09:57 AM ET
    What is the market capitalization of GoodRx Holdings, Inc. - Class A Common Stock?
    The market capitalization of GoodRx Holdings, Inc. - Class A Common Stock is 950.65M
    How many shares of GoodRx Holdings, Inc. - Class A Common Stock are outstanding?
    GoodRx Holdings, Inc. - Class A Common Stock has 951M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.